The market for GLP-1-based injectable therapies in India has reportedly surged tenfold within the past year, driven significantly by the introduction of generic semaglutide in March 2026. This information emerges from a recent analysis of the...
The diabetes and obesity medication Mounjaro, produced by US pharmaceutical company Eli Lilly, has now surpassed Merck's cancer treatment Keytruda to become the leading-selling drug globally. This significant shift represents a notable change in the pharmaceutical...
A recent initiative by the Union health ministry to mandate blue lines on all antimicrobial medicines has encountered significant opposition from various sectors of...
Recognising that climate change is a global concern, big pharma is taking action at a global level. Pharmaceutical corporations are already working on initiatives...
In today’s world where sustainability and responsible business practice is no longer an option, a dilemma has emerged in the pharma sector regarding the...
By Dr Bharat Champaneria, Kaka Ba Hospital, CSR initiative of Cadilla Pharmaceuticals.
Ingestion of bulk drugs by the rising demands in the global pharmaceutical markets...
